ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 130 filers reported holding ASCENDIS PHARMA A/S in Q3 2019. The put-call ratio across all filers is 0.17 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $836,392 | +6.5% | 8,932 | +1.5% | 0.00% | 0.0% |
| Q2 2023 | $785,400 | +46.5% | 8,800 | +76.0% | 0.00% | 0.0% |
| Q1 2023 | $536,100 | +58.0% | 5,000 | +79.9% | 0.00% | – |
| Q4 2022 | $339,399 | -51.0% | 2,779 | -52.9% | 0.00% | -100.0% |
| Q1 2022 | $692,000 | +207.6% | 5,900 | +318.4% | 0.00% | – |
| Q3 2021 | $225,000 | -60.4% | 1,410 | -67.3% | 0.00% | – |
| Q2 2021 | $568,000 | +2.2% | 4,314 | +0.0% | 0.00% | – |
| Q1 2021 | $556,000 | -22.7% | 4,313 | +0.1% | 0.00% | – |
| Q4 2020 | $719,000 | +5.7% | 4,310 | -2.0% | 0.00% | – |
| Q3 2020 | $680,000 | -42.5% | 4,399 | -44.9% | 0.00% | -100.0% |
| Q2 2020 | $1,182,000 | +52.7% | 7,990 | +16.3% | 0.00% | 0.0% |
| Q1 2020 | $774,000 | -64.1% | 6,869 | -55.7% | 0.00% | -50.0% |
| Q4 2019 | $2,156,000 | +436.3% | 15,504 | +271.2% | 0.00% | – |
| Q3 2019 | $402,000 | +33.1% | 4,177 | -72.2% | 0.00% | – |
| Q3 2016 | $302,000 | +42.5% | 15,031 | -6.2% | 0.00% | – |
| Q2 2016 | $212,000 | +14.0% | 16,030 | +60.0% | 0.00% | – |
| Q1 2016 | $186,000 | -9.3% | 10,016 | -10.7% | 0.00% | – |
| Q4 2015 | $205,000 | – | 11,220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 133,691 | $13,805,000 | 36.44% |
| RA Capital Management | 7,567,900 | $781,462,000 | 16.67% |
| Q Global Advisors, LLC | 145,209 | $16,699,000 | 11.49% |
| BERYLSON CAPITAL PARTNERS, LLC | 51,000 | $5,266,000 | 8.70% |
| Spyglass Capital Management LLC | 949,915 | $98,088,000 | 6.94% |
| Paradigm Biocapital Advisors LP | 497,347 | $51,356,000 | 6.85% |
| Avoro Capital Advisors LLC | 2,850,000 | $294,291,000 | 5.44% |
| Deep Track Capital, LP | 1,000,000 | $103,260,000 | 4.73% |
| Finepoint Capital LP | 123,400 | $12,742,000 | 4.19% |
| Deep Track Capital, LP | 800,000 | $82,608,000 | 3.78% |